Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events
Top Cited Papers
Open Access
- 8 December 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (12) , 3947-3957
- https://doi.org/10.1002/art.20622
Abstract
Objective To determine the baseline (time 0) risk factors associated with the subsequent occurrence of vascular events in a multiethnic US cohort (LUMINA [LUpus in MInorities: NAture versus nurture]) of patients with systemic lupus erythematosus (SLE). Methods Five hundred forty‐six LUMINA patients were assessed at time 0 for traditional and nontraditional (disease‐related) risk factors for vascular events. These were defined as 1) cardiovascular (myocardial infarction and/or definite or classic angina and/or the undergoing of a vascular procedure for myocardial infarction [coronary artery bypass graft]), 2) cerebrovascular (stroke), and 3) peripheral vascular (arterial claudication and/or gangrene or significant tissue loss and/or arterial thrombosis in peripheral arteries). The observation time (followup time in the cohort) was the interval between time 0 and the last visit. The unit of analysis was the patient and not each vascular event. Variables at time 0 and vascular events were examined by univariable and multivariable (logistic and Cox proportional hazards regression) analyses. Age, sex, ethnicity, followup time, and all known risk factors for the occurrence of vascular events were included in the model. Results Thirty‐four patients (6.2%) developed one or more vascular event after time 0. The overall median duration of followup in the cohort was 73.8 months (range 10.8–111.3 months). Vascular events (13 cardiovascular, 18 cerebrovascular, 5 peripheral vascular) occurred in 7 Hispanics from Texas (6.5%), 1 Hispanic from Puerto Rico (1.2%), 15 African Americans (7.5%), and 11 Caucasians (7.1%). The mean total number of traditional risk factors was significantly higher in patients who developed vascular events than in those who did not (7.1 versus 5.6). Independent predictors of vascular events were older age, current smoking status, longer followup time, elevated serum levels of C‐reactive protein (CRP), and the presence of any antiphospholipid antibody. The same variables were identified when time‐dependent analyses were performed, although azathioprine use was also found to be a contributing factor. Conclusion Smoking, previously not reported in SLE, emerged as a predictor of vascular events and should be strongly discouraged. Antiphospholipid antibodies and CRP support the role of inflammation and autoimmunity in the development of accelerated atherosclerosis in SLE. Ethnicity was not associated with vascular events in our patients.Keywords
Funding Information
- NIH (R01-AR-42503, M01-RR-02558, M01-RR-00032, 1P20-RR-11126)
- The Mary Kirkland Scholar Award Program
This publication has 56 references indexed in Scilit:
- Race-Specific Differences in Endothelial FunctionCirculation, 2004
- Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulationsRheumatology, 2003
- Antibodies to high‐density lipoprotein and β2‐glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndromeArthritis & Rheumatism, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Myocardial Infarction in Patients with Systemic Lupus Erythematosus with Normal Findings from Coronary Arteriography and Without Coronary VasculitisAngiology, 1999
- Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosusArthritis & Rheumatism, 1999
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997
- Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDLClinical and Experimental Immunology, 1995
- Cardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 PatientsAngiology, 1985
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982